0

538837

JSTL

img img img img
No Data Available

Jeevan Scientific Technology L Share Price Update

As of the latest trading session, Jeevan Scientific Technology L share price is currently at ₹66.15, which is up by ₹3.15 from its previous closing. Today, the stock has fluctuated between ₹63.00 and ₹66.15. Over the past year, Jeevan Scientific Technology L has achieved a return of 50.47%. In the last month alone, the return has been -13.86%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Jeevan Scientific Technology L fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    123.00

  • P/E Ratio (TTM)

    -94.52

  • Beta

    0.68

  • Book Value / share

    32.81

  • Return on equity

    1.48%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    2.30

info icon alternate text

Jeevan Scientific Technology L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 16.91
Operating Expense 13.99
Net Profit 2.30
Net Profit Margin (%) 13.60
Earnings Per Share (EPS) 1.45
EBITDA 4.83
Effective Tax Rate (%) 25.80
Particulars SEP 2025 (Values in Cr)
Revenue 10.43
Operating Expense 10.79
Net Profit -0.09
Net Profit Margin (%) -0.86
Earnings Per Share (EPS) -0.05
EBITDA 1.74
Effective Tax Rate (%) 11.11
Particulars JUN 2025 (Values in Cr)
Revenue 8.22
Operating Expense 11.18
Net Profit -2.16
Net Profit Margin (%) -26.27
Earnings Per Share (EPS) -1.36
EBITDA -0.73
Effective Tax Rate (%) 16.60
Particulars MAR 2025 (Values in Cr)
Revenue 8.92
Operating Expense 11.70
Net Profit -1.34
Net Profit Margin (%) -15.02
Earnings Per Share (EPS) -0.86
EBITDA -0.76
Effective Tax Rate (%) 49.43
Particulars DEC 2024 (Values in Cr)
Revenue 11.87
Operating Expense 11.32
Net Profit 0.32
Net Profit Margin (%) 2.69
Earnings Per Share (EPS) 0.21
EBITDA 2.26
Effective Tax Rate (%) 57.14
Particulars MAR 2025 (Values in Cr)
Revenue 43.61
Operating Expense 43.47
Net Profit 0.74
Net Profit Margin (%) 1.69
Earnings Per Share (EPS) 0.47
EBITDA 7.10
Effective Tax Rate (%) 3.89
Particulars MAR 2024 (Values in Cr)
Revenue 38.50
Operating Expense 40.41
Net Profit -1.05
Net Profit Margin (%) -2.72
Earnings Per Share (EPS) -0.68
EBITDA 5.05
Effective Tax Rate (%) 14.63
Particulars MAR 2023 (Values in Cr)
Revenue 36.18
Operating Expense 40.86
Net Profit -3.00
Net Profit Margin (%) -8.29
Earnings Per Share (EPS) -1.96
EBITDA 2.34
Effective Tax Rate (%) 17.12
Particulars MAR 2022 (Values in Cr)
Revenue 56.55
Operating Expense 44.12
Net Profit 12.26
Net Profit Margin (%) 21.67
Earnings Per Share (EPS) 8.15
EBITDA 22.99
Effective Tax Rate (%) 33.18
Particulars MAR 2021 (Values in Cr)
Revenue 41.39
Operating Expense 29.66
Net Profit 11.26
Net Profit Margin (%) 27.20
Earnings Per Share (EPS) 7.40
EBITDA 18.86
Effective Tax Rate (%) 14.56
Particulars MAR 2025 (Values in Cr)
Book Value / Share 31.54
ROE % 0.14
ROCE % 2.79
Total Debt to Total Equity 0.35
EBITDA Margin 17.32
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.28
ROE % -2.75
ROCE % -1.04
Total Debt to Total Equity 0.24
EBITDA Margin 13.39
Particulars MAR 2023 (Values in Cr)
Book Value / Share 31.13
ROE % -6.20
ROCE % -4.33
Total Debt to Total Equity 0.23
EBITDA Margin 6.72
Particulars MAR 2022 (Values in Cr)
Book Value / Share 33.06
ROE % 21.66
ROCE % 27.40
Total Debt to Total Equity 0.27
EBITDA Margin 27.51
Particulars MAR 2021 (Values in Cr)
Book Value / Share 22.89
ROE % 40.32
ROCE % 36.52
Total Debt to Total Equity 0.49
EBITDA Margin 42.34
Particulars MAR 2025 (Values in Cr)
Book Value / Share 32.16
ROE % 1.48
ROCE % 3.13
Total Debt to Total Equity 0.19
EBITDA Margin 16.42
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.53
ROE % -2.16
ROCE % -0.85
Total Debt to Total Equity 0.15
EBITDA Margin 13.17
Particulars MAR 2023 (Values in Cr)
Book Value / Share 31.21
ROE % -6.07
ROCE % -4.32
Total Debt to Total Equity 0.22
EBITDA Margin 6.66
Particulars MAR 2022 (Values in Cr)
Book Value / Share 33.06
ROE % 22.02
ROCE % 27.70
Total Debt to Total Equity 0.26
EBITDA Margin 33.53
Particulars MAR 2021 (Values in Cr)
Book Value / Share 23.69
ROE % 36.81
ROCE % 33.44
Total Debt to Total Equity 0.46
EBITDA Margin 46.97
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.24
Total Assets 78.29
Total Liabilities 78.29
Total Equity 50.07
Share Outstanding 1
Price to Book Ratio 1.25
Return on Assets (%) 0.17
Return on Capital (%) 0.21
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.54
Total Assets 67.86
Total Liabilities 67.86
Total Equity 48.63
Share Outstanding 1
Price to Book Ratio 1.63
Return on Assets (%) -1.91
Return on Capital (%) -2.18
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.83
Total Assets 65.92
Total Liabilities 65.92
Total Equity 48.42
Share Outstanding 1
Price to Book Ratio 1.56
Return on Assets (%) -4.62
Return on Capital (%) -5.56
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 29.71
Total Assets 77.87
Total Liabilities 77.87
Total Equity 50.58
Share Outstanding 1
Price to Book Ratio 3.93
Return on Assets (%) 15.33
Return on Capital (%) 18.92
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 6.21
Total Assets 65.97
Total Liabilities 65.97
Total Equity 35.02
Share Outstanding 1
Price to Book Ratio 2.59
Return on Assets (%) 17.79
Return on Capital (%) 25.88
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 70.61
Total Liabilities 70.61
Total Equity 50.91
Share Outstanding 1
Price to Book Ratio 1.25
Return on Assets (%) 1.04
Return on Capital (%) 1.24
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.51
Total Assets 59.91
Total Liabilities 59.91
Total Equity 48.80
Share Outstanding 1
Price to Book Ratio 1.63
Return on Assets (%) -1.75
Return on Capital (%) -1.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 6.12
Total Assets 63.75
Total Liabilities 63.75
Total Equity 48.31
Share Outstanding 1
Price to Book Ratio 1.56
Return on Assets (%) -4.71
Return on Capital (%) -5.51
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 29.71
Total Assets 77.87
Total Liabilities 77.87
Total Equity 50.58
Share Outstanding 1
Price to Book Ratio 3.93
Return on Assets (%) 15.74
Return on Capital (%) 19.43
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 5.68
Total Assets 63.77
Total Liabilities 63.77
Total Equity 36.24
Share Outstanding 1
Price to Book Ratio 2.59
Return on Assets (%) 17.65
Return on Capital (%) 24.16
Particulars MAR 2025 (Values in Cr)
Net Income 0.05
Cash from Operations 10.07
Cash from Investing -15.61
Cash from Financing 5.24
Net change in Cash -0.30
Free Cash Flow 26.10
Particulars MAR 2024 (Values in Cr)
Net Income -1.60
Cash from Operations 4.66
Cash from Investing -11.52
Cash from Financing 2.34
Net change in Cash -6.28
Free Cash Flow 16.69
Particulars MAR 2023 (Values in Cr)
Net Income -3.68
Cash from Operations -3.65
Cash from Investing -6.93
Cash from Financing -9.54
Net change in Cash -22.87
Free Cash Flow 4.51
Particulars MAR 2022 (Values in Cr)
Net Income 18.34
Cash from Operations 25.64
Cash from Investing -1.20
Cash from Financing 5.67
Net change in Cash 24.02
Free Cash Flow 27.98
Particulars MAR 2021 (Values in Cr)
Net Income 13.64
Cash from Operations 8.95
Cash from Investing -0.79
Cash from Financing -0.13
Net change in Cash 4.01
Free Cash Flow 9.74
Particulars MAR 2025 (Values in Cr)
Net Income 0.77
Cash from Operations 2.83
Cash from Investing -9.84
Cash from Financing 6.57
Net change in Cash -0.30
Free Cash Flow 13.14
Particulars MAR 2024 (Values in Cr)
Net Income -1.22
Cash from Operations 4.50
Cash from Investing -4.69
Cash from Financing -3.65
Net change in Cash -5.61
Free Cash Flow 9.72
Particulars MAR 2023 (Values in Cr)
Net Income -3.61
Cash from Operations -3.53
Cash from Investing -7.26
Cash from Financing -10.02
Net change in Cash -23.59
Free Cash Flow 2.72
Particulars MAR 2022 (Values in Cr)
Net Income 18.34
Cash from Operations 25.64
Cash from Investing -1.20
Cash from Financing 5.67
Net change in Cash 24.02
Free Cash Flow 27.98
Particulars MAR 2021 (Values in Cr)
Net Income 13.17
Cash from Operations 8.37
Cash from Investing -0.79
Cash from Financing -0.13
Net change in Cash 3.80
Free Cash Flow 9.17
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7549.90 59.76 11.94 108555.98 6017.95 8099.00
FORTIS MALAR HOSPITALS LIMITED 50.79 20.99 2.77 95.19 46.65 98.70
SHREE PACETRONIX LTD. 115.00 16.99 2.58 42.26 61.11 283.15
TRANSGENE BIOTEK LTD. 2.50 0.00 2.05 18.94 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 7492.85 74.18 11.56 107735.69 6017.95 8099.00
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 37.06 0.00 -10.76 27.68 28.34 57.48
KOVAI MEDICAL CENTER & HOSPITA 5106.00 23.69 4.69 5585.96 5049.80 6725.00

Jeevan Scientific Technology L shareholding pattern

Holding

61.95%
38.04%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Jeevan Scientific Technology L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
61.76 2.09 redarrow
red-green-graph indicator
12 Bearish
4 Bullish
  • 5 Days 61.80
  • 26 Days 65.70
  • 10 Days 63.70
  • 50 Days 65.30
  • 12 Days 64.20
  • 100 Days 62.00
  • 20 Days 65.40
  • 200 Days 56.80
59.88 PIVOT

First Support

57.76

First Resistance

62.61

Second Support

55.03

Second Resistance

64.73

Third Support

52.91

Third Resistance

67.46

RSI

36.98

ADX

19.49

MACD

-1.42

Williams % R

-76.71

Commodity Channel Index (CCI)

-166.65

Date

2026-03-16

Week

14729.00

Same Day

34926.00

Month

12328.00

1 Year

0.69

3 Year

0.67

Over 1 Month

-13.86%

down

Over 1 Year

50.47%

down

Over 3 Months

-0.24%

down

Over 3 Years

6.20%

down

Over 6 Months

58.97%

down

Over 5 Years

-2.75%

down

Jeevan Scientific Technology L Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
21 Sep 2022 1.2 Final 23 Sep 2022 Equity shares
07 Sep 2021 0.5 Final 08 Sep 2021 Equity shares

Top Gainers

Jeevan Scientific Technology L Share Price

Jeevan Scientific Technology Limited, erstwhile known as Jeevan Softech Limited was incorporated on 2nd February, 1999 to carry on the business Clinical research, Data Management Services. The Company was promoted by Krishna Kishore Kuchipudi and K Vanaja. The Company is an Independent Clinical Contract Research Organization offering reliable, cost effective and technology-driven clinical research solutions to various clients across the globe. The name of the Company was changed from Jeevan Softech Limited to Jeevan Scientific Technology Limited in April, 2012.

The Company started with an overall focus on Products Development, International and Domestic markets and Training segment.

During the year 2000-01, company had developed and released products for Edible Oil Industry,Engineering Industry,Hospital Management.

The company is the member of STPI under 100% Export oriented unit Registration scheme and also achieved Software Exports during 2000-01,to USA based organisation C.S.Consultants Inc.

The company entered into an agreement with the University of Madras as a study centre for Hyderabad to provide MCA, M. Sc., MBA through distance education mode by the Jeevan School of Computer Sciences, a division of Jeevan Softech Limited.

In 2011, the Company started Medical Writing Services. It opened Jeevan Scientific New Corporate and Bioanalytical Lab facility in December, 2014. The Clinical Pharmacology Unit with 132 bed capacity opened in Balanagar, Hyderabad in October, 2016.

Thereafter, it completed BA/BE studies on 08 June, 2017. In FY 2018-19, the Company acquired nearly 10 LC-MS/MS systems which got launched to accommodate possible work. Thereafter, it started offering clinical research services like Bioavailability/Bioequivalence studies and Phase I to Phase IV services to pharmaceutical and biotechnology industries.

In 2021-22, Company launched its first UK MHRA inspection of both facilities.

Further, Company invested in 20,00,000 equity shares of Rs 10 each of Nayas Laboratories Private Limited, constituting 88.9% of the post paid up equity share capital of Nayas Laboratories Private Limited, making it a subsidiary of the Company in 2022-23.

Parent organization Indian Private
NSE symbol [-]
Founded 1999
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Jeevan Scientific Technology Ltd?

Answer Field

Jeevan Scientific Technology Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 61.76 as on Mar 20 2026 03:30 PM.

What is the Market Cap of Jeevan Scientific Technology Ltd Share?

Answer Field

The market cap of Jeevan Scientific Technology Ltd for NSE ₹ 0.00 & for BSE ₹ 123.00 as on Mar 20 2026 03:30 PM.

What is the 52 Week High and Low of Jeevan Scientific Technology Ltd?

Answer Field

The 52 Week High and Low of Jeevan Scientific Technology Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 76.99 and ₹ 32.85.

What is 1 year return for Jeevan Scientific Technology Ltd?

Answer Field

The 1 year returns on the stock has been 50.47%.

What is the P/E Ratio of Jeevan Scientific Technology Ltd Share?

Answer Field

As on Mar 20 2026 03:30 PM the price-to-earnings (PE) ratio for Jeevan Scientific Technology Ltd share is -94.52.

What is the PB ratio of Jeevan Scientific Technology Ltd Share?

Answer Field

As on Mar 20 2026 03:30 PM, the price-to-book (PB) ratio for Jeevan Scientific Technology Ltd share is 32.81.

How to Buy Jeevan Scientific Technology Ltd Share?

Answer Field

You can trade in Jeevan Scientific Technology Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Jeevan Scientific Technology Ltd Share on Bajaj Broking App?

Answer Field

To buy Jeevan Scientific Technology Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Jeevan Scientific Technology Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59